SEC Comment Letter for Enlivex Ltd. (ENLV) (CIK 0001596812) (ENLV) — Apr 27, 2026
Enlivex Ltd. (ENLV) (CIK 0001596812)
Date: April 27, 2026 · CIK: 0001596812 · Accession: 0000000000-26-004262
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295215
Letter
April 27, 2026 Oren Hershkovitz Chief Executive Officer Enlivex Ltd. 14 Einstein Street Ness Ziona Israel 7403618 Re: Enlivex Ltd. Registration Statement on Form F-3 Filed April 21, 2026 File No. 333-295215 Dear Oren Hershkovitz: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Drew M. Altman, Esq.
Show Raw Text
April 27, 2026 Oren Hershkovitz Chief Executive Officer Enlivex Ltd. 14 Einstein Street Ness Ziona Israel 7403618 Re: Enlivex Ltd. Registration Statement on Form F-3 Filed April 21, 2026 File No. 333-295215 Dear Oren Hershkovitz: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Drew M. Altman, Esq.